UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Singing exercises reduce snoring
Date: Aug-20-2013Are you - or your partner - a chronic snorer? Joining a choir or taking singing lessons could help. A UK study found that a program of vocal exercises designed by a singing teacher helped reduce snoring. The clinical trial, by Exeter University and the Royal Devon and Exeter NHS Foundation Trust, showed that the singing exercises, which strengthen certain throat muscles, also alleviated symptoms of obstructive sleep apnea, a condition in which people stop breathing during deep sleep...
Longer waiting times for GP appointments predicted as concerned GPs raise fears about the impact of cuts for patient care, UK
Date: Aug-20-2013Over 70% of GPs are forecasting longer waiting times for GP appointments within the next two years - as nearly half (47%) reveal that they have cut back on the range of services they provide for their patients. In the latest survey by the Royal College of General Practitioners (RCGP) highlighting the growing crisis in general practice, more than 80% of respondents said that they now have insufficient resources to provide high quality patient care...
A way for China to resolve its 'immigration' dilemma
Date: Aug-20-2013University of Washington geographer Kam Wing Chan is in China this week, explaining how that country can dismantle its 55-year-old system that limits rural laborers from moving to and settling in cities and qualifying for basic social benefits. It's an idea that he says makes economic and moral sense. China's "hukou" household registration system was established in 1958 as a way of maintaining cheap farm labor to grow food for urban dwellers...
Glioblastoma response to anti-angiogenesis therapy revealed by new MR analysis technique
Date: Aug-20-2013A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective...
New epidemiological study in malignant hyperthermia reinforces the effectiveness of Dantrium® in reducing fatal anaesthetic reaction
Date: Aug-20-2013For the first time, a new Canadian epidemiologic study reveals that a 15.5 per cent incidence of adverse anaesthetic reactions is triggered by succinylcholine alone. In line with previous findings, the study also further underlines that early recognition and prompt administration of dantrolene intravenous are critical for patient survival and reduction of complications.[1] The study reviews one hundred twenty-nine proband* survivors of adverse anaesthetic reactions, whose malignant hyperthermia susceptible status was confirmed by caffeine-halothane contracture testing...
Bypassing immune rejection in stem-cell-based therapies
Date: Aug-20-2013The scientific community has held tremendous hope for the eventual emergence of stem cell transplantation as a broadly applicable and highly effective therapeutic strategy. However, the realization of this hope has been plagued by the indomitable immune response to the transplantation of human embryonic stem cell (hESC) derivatives, which prevents the engraftment and long-term survival necessary for functional recovery or preservation of the host tissue...
Anglia Ruskin experts want introduction of new treatment model for ductal carcinoma in situ (DCIS) patients
Date: Aug-20-2013Breast cancer specialists at Anglia Ruskin University are proposing the introduction of a new model to provide safer treatment for patients with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer. Writing in the latest edition of The Lancet Oncology journal, Professor John Benson and Professor Gordon Wishart state that therapies such as radiotherapy and tamoxifen, which can impair quality of life and increase health-care costs, are not necessary for all patients...
Health Canada approves JETREA® for the treatment of symptomatic vitreomacular adhesion
Date: Aug-20-2013ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, has announced that Health Canada has approved JETREA(R) (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA). The priority review of the New Drug Submission for JETREA in Canada was conducted within 180 calendar days. Canada is the first market where JETREA(R) is approved outside the US and Europe...
Instructions for planarian regeneration provided by muscle cells
Date: Aug-20-2013By studying the planarian flatworm, a master of regenerating missing tissue and repairing wounds, Whitehead Institute Member Peter Reddien and his lab have identified an unexpected source of position instruction: the muscle cells in the planarian body wall. "I was completely surprised. We had no idea it would be muscle," says Reddien, who is also an associate professor of biology at MIT. "Finding such a cellular system for positional control in an adult regenerative animal was unanticipated and is very informative for understanding regeneration...
Topical formulation identified for prolonged graft survival in corneal transplants
Date: Aug-20-2013Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of therapies that modulate the immune system to treat cancer, infectious diseases, transplant rejection, autoimmune and inflammatory diseases, has announced the publication of key findings on its soluble recombinant human CD83 protein (sCD83) in cornea transplants. The study, conducted in rodents, demonstrates that CD83 can modulate the immune system and promote graft survival...
Stay Connected
